Zanganeh Mahkam

CIK 00015076503 companiesHAYWARD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001507650

Recent Transactions

50 trades

Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2026-06-12$13.12/sh+3,810,000→ 573,883,879 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2026-06-11+14,504→ 14,504 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2026-06-11+30,000→ 30,000 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2026-06-04$14.60/sh+100,000→ 25,824,474 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2026-01-02$8.76/sh+11,232→ 11,232 total
Award
Summit Therapeutics Inc.$SMMT
Common Stock
2025-10-21$18.74/sh+266,808→ 25,724,474 total
Award
Summit Therapeutics Inc.$SMMT
Common Stock
2025-10-21$18.74/sh+13,980,789→ 570,073,879 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2025-10-21$18.74/sh+26,680→ 76,680 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2025-09-11$18.07/sh+5,000→ 556,093,090 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2025-09-10$17.68/sh+333,394→ 556,088,090 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2025-08-15+30,000→ 30,000 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2025-08-15+24,134→ 24,134 total
Exercise/Conversion
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-05-30−74,545→ 0 total
Exercise/Conversion
Summit Therapeutics Inc.$SMMT
Common Stock
2025-05-30$2.64/sh+74,545→ 555,754,696 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-04-29+400,000→ 400,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-04-29+1,040,000→ 1,040,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-04-29+9,590,558→ 9,590,558 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Common Stock
2025-04-08$1.58/sh+3,985,055→ 555,680,151 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Warrant (right to buy)
2025-04-08+3,985,055→ 0 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2025-02-03$11.00/sh+30,121→ 725,395 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2025-02-03−30,121→ 0 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2025-01-24$11.00/sh+30,121→ 695,274 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2025-01-24−30,121→ 0 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-01-02$9.18/sh+10,724→ 10,724 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Warrant (right to buy)
2024-10-03−315,681→ 0 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Common Stock
2024-10-03$1.58/sh+315,681→ 10,199,776 total
Award
Summit Therapeutics Inc.$SMMT
Common Stock
2024-09-11$22.70/sh+44,052→ 24,967,852 total
Award
Summit Therapeutics Inc.$SMMT
Performance Stock Option (right to buy)
2024-08-23+2,397,640→ 2,397,640 total
Award
Summit Therapeutics Inc.$SMMT
Performance Stock Option (right to buy)
2024-08-23+260,000→ 260,000 total
Award
Summit Therapeutics Inc.$SMMT
Performance Stock Option (right to buy)
2024-08-23+100,000→ 100,000 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2024-08-09+200,000→ 200,000 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2024-07-03+30,121→ 30,121 total
Exercise of In-Money
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2024-07-03+60,242→ 665,153 total
Purchase
PULSE BIOSCIENCES, INC.$PLSE
Warrant (right to buy)
2024-07-03+30,121→ 30,121 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2024-06-06+20,000→ 20,000 total
Award
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2024-06-06+8,247→ 8,247 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2024-03-27$3.71/sh+20,000→ 50,000 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2024-03-27$3.72/sh+34,321→ 24,923,800 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2024-03-27$3.72/sh+26,000→ 520,814 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2024-03-26$3.75/sh+30,000→ 30,000 total
Purchase
Summit Therapeutics Inc.$SMMT
Common Stock
2023-12-12$2.07/sh+5,000→ 494,814 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Warrant (right to buy)
2023-12-11−315,681→ 0 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Warrant (right to buy)
2023-12-11−489,814→ 0 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Common Stock
2023-12-11$1.44/sh+489,814→ 489,814 total
Exercise of In-Money
Summit Therapeutics Inc.$SMMT
Common Stock
2023-12-11$1.58/sh+315,681→ 24,889,479 total
Exercise/Conversion
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2023-11-13−56,075→ 0 total
Exercise/Conversion
PULSE BIOSCIENCES, INC.$PLSE
Stock Option (right to buy)
2023-11-13−20,000→ 0 total
Exercise/Conversion
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2023-11-13$2.14/sh+56,075→ 604,911 total
Exercise/Conversion
PULSE BIOSCIENCES, INC.$PLSE
Common Stock
2023-11-13$2.14/sh+20,000→ 548,836 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2023-10-13+11,988,198→ 11,988,198 total

Companies

Recent Filings

Address

C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY

HAYWARD, CA, 94545

View on SEC.gov